These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31072671)

  • 1. Listing practices and graft utilization of hepatitis C-positive deceased donors in liver and kidney transplant.
    Kling CE; Perkins JD; Biggins SW; Johnson CK; Limaye AP; Sibulesky L
    Surgery; 2019 Jul; 166(1):102-108. PubMed ID: 31072671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.
    Sibulesky L; Kling CE; Blosser C; Johnson CK; Limaye AP; Bakthavatsalam R; Leca N; Perkins JD
    Am J Transplant; 2018 Oct; 18(10):2465-2472. PubMed ID: 29451354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.
    Ariyamuthu VK; Sandikci B; AbdulRahim N; Hwang C; MacConmara MP; Parasuraman R; Atis A; Tanriover B
    Transpl Infect Dis; 2020 Feb; 22(1):e13204. PubMed ID: 31677214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.
    Bowring MG; Shaffer AA; Massie AB; Cameron A; Desai N; Sulkowski M; Garonzik-Wang J; Segev DL
    Am J Transplant; 2019 Aug; 19(8):2329-2341. PubMed ID: 30861279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
    Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
    Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.
    Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Performance of Unilateral Kidney Transplants from Deceased Donors.
    Husain SA; Chiles MC; Lee S; Pastan SO; Patzer RE; Tanriover B; Ratner LE; Mohan S
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):118-127. PubMed ID: 29217537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.
    Chang SH; Merzkani M; Lentine KL; Wang M; Axelrod DA; Anwar S; Schnitzler MA; Wellen J; Chapman WC; Alhamad T
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):251-261. PubMed ID: 33451990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death.
    Singh SK; Kim SJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):317-23. PubMed ID: 26668028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
    Chavalitdhamrong D; Gill J; Takemoto S; Madhira BR; Cho YW; Shah T; Bunnapradist S
    Transplantation; 2008 Jun; 85(11):1573-9. PubMed ID: 18551062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999.
    Fong TL; Bunnapradist S; Jordan SC; Cho YW
    Transplantation; 2002 Jan; 73(1):85-9. PubMed ID: 11792984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.
    Kucirka LM; Peters TG; Segev DL
    Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts.
    Scalea JR; Barth RN; Munivenkatappa R; Philosophe B; Cooper M; Whitlow V; LaMattina JC
    Transplantation; 2015 Jun; 99(6):1192-6. PubMed ID: 25340605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.